![]() |
|
---|---|
Systematic (IUPAC) name | |
N-(6,8-Difluoro-2-methyl-4-quinolinyl)-N'-[4-(dimethylamino)phenyl]urea | |
Clinical data | |
Pregnancy cat. | ? |
Legal status | ? |
Identifiers | |
CAS number | 288150-92-5 |
ATC code | ? |
Chemical data | |
Formula | C19H18F2N4O |
Mol. mass | 356.368 g/mol |
SMILES | eMolecules & PubChem |
![]() |
SB-408,124 is a drug which is a non-peptide antagonist selective for the orexin receptor subtype OX1, with around 70x selectivity for OX1 over OX2 receptors, and improved oral bioavailability compared to the older OX1 antagonist SB-334,867. It is used in scientific research into the function of orexinergic neurons in the body.[1][2]
|
![]() |
This sedative-related article is a stub. You can help Wikipedia by expanding it. |